Compensation for subjects of medical research: the moral rights of patients and the power of research ethics committees
Awareness of the morally significant distinction between research and innovative therapy reveals serious gaps in the legal provision for compensation in the UK for injured subjects of medical research. Major problems are limitations inherent in negligence actions and a culture that emphasises indemn...
| Autor principal: | |
|---|---|
| Tipo de documento: | Electrónico Artículo |
| Lenguaje: | Inglés |
| Verificar disponibilidad: | HBZ Gateway |
| Journals Online & Print: | Gargar...
|
| Fernleihe: | Fernleihe für die Fachinformationsdienste |
| Publicado: |
BMJ Publ.
1997
|
| En: |
Journal of medical ethics
Año: 1997, Volumen: 23, Número: 3, Páginas: 181-185 |
| Acceso en línea: |
Volltext (JSTOR) Volltext (kostenfrei) Volltext (kostenfrei) |
MARC
| LEADER | 00000naa a22000002 4500 | ||
|---|---|---|---|
| 001 | 1816115533 | ||
| 003 | DE-627 | ||
| 005 | 20220908053240.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220908s1997 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1136/jme.23.3.181 |2 doi | |
| 035 | |a (DE-627)1816115533 | ||
| 035 | |a (DE-599)KXP1816115533 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 1 |2 ssgn | ||
| 100 | 1 | |a Guest, S. |e VerfasserIn |4 aut | |
| 245 | 1 | 0 | |a Compensation for subjects of medical research: the moral rights of patients and the power of research ethics committees |
| 264 | 1 | |c 1997 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Awareness of the morally significant distinction between research and innovative therapy reveals serious gaps in the legal provision for compensation in the UK for injured subjects of medical research. Major problems are limitations inherent in negligence actions and a culture that emphasises indemnifying researchers before compensating victims. Medical research morally requires compensation on a no-fault basis even where there is proper consent on the part of the research subject. In particular, for drug research, there is insufficient provision in the current patient guidelines of the Association of the British Pharmaceutical Industry, since they make "no legal commitment" to paying compensation for injury to patient subjects. There is a need for the provision of both adequate insurance and contractual arrangements for making payments. The solution is for Local Research Ethics Committees (LRECs) to make use of their power to withhold approval of medical research where compensation is not legally enforceable. | ||
| 601 | |a Patient | ||
| 773 | 0 | 8 | |i Enthalten in |t Journal of medical ethics |d London : BMJ Publ., 1975 |g 23(1997), 3, Seite 181-185 |h Online-Ressource |w (DE-627)323607802 |w (DE-600)2026397-1 |w (DE-576)260773972 |x 1473-4257 |7 nnns |
| 773 | 1 | 8 | |g volume:23 |g year:1997 |g number:3 |g pages:181-185 |
| 856 | |3 Volltext |u http://www.jstor.org/stable/27717943 |x JSTOR | ||
| 856 | |u https://jme.bmj.com/content/medethics/23/3/181.full.pdf |x unpaywall |z Vermutlich kostenfreier Zugang |h publisher [open (via free pdf)] | ||
| 856 | 4 | 0 | |u https://doi.org/10.1136/jme.23.3.181 |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u http://jme.bmj.com/content/23/3/181.abstract |x Verlag |z kostenfrei |3 Volltext |
| 935 | |a mteo | ||
| 936 | u | w | |d 23 |j 1997 |e 3 |h 181-185 |
| 951 | |a AR | ||
| ELC | |a 1 | ||
| ITA | |a 1 |t 1 | ||
| LOK | |0 000 xxxxxcx a22 zn 4500 | ||
| LOK | |0 001 4185567413 | ||
| LOK | |0 003 DE-627 | ||
| LOK | |0 004 1816115533 | ||
| LOK | |0 005 20220908053240 | ||
| LOK | |0 008 220908||||||||||||||||ger||||||| | ||
| LOK | |0 035 |a (DE-Tue135)IxTheo#2022-08-02#ABD4FB09FEDB4000BFC9528380424A2E07FCEC74 | ||
| LOK | |0 040 |a DE-Tue135 |c DE-627 |d DE-Tue135 | ||
| LOK | |0 092 |o n | ||
| LOK | |0 852 |a DE-Tue135 | ||
| LOK | |0 852 1 |9 00 | ||
| LOK | |0 866 |x JSTOR#http://www.jstor.org/stable/27717943 | ||
| LOK | |0 935 |a ixzs |a ixrk |a zota | ||
| OAS | |a 1 | ||
| ORI | |a SA-MARC-ixtheoa001.raw | ||